Clinical Trial Update: Perfusion by Arterial Spin Labelling Following Single Dose Tadalafil in Small Vessel Disease (PASTIS) Trial [Phase 2]

View source ↗

Summary

Phase 2 trial update on perfusion using arterial spin labeling after a single dose of tadalafil in small vessel disease-related dementia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dementia Vascular

Drugs mentioned

• TADALAFIL (TADALAFIL)

Snippet

Sponsor: St George's, University of London | Conditions: Dementia, Vascular | Phase 2 | Status: COMPLETED